Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hip implant tested for safer fracture repair

NCT ID NCT06885359

Recruiting now Disease control Sponsor: Limacorporate S.p.a Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study looks at how well a specific hip implant (CoCrMo LOCK bipolar femoral head) works for people who have had a hip fracture. Researchers will check how many patients need a second surgery or experience complications like dislocation within two years. The study includes 60 adults who received this implant starting in 2023 and who could walk before their fracture.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CoCrMo LOCK bipolar femoral head (hip implant)
What this could lead to
If the implant performs well, it could confirm a safe and effective option for hip fracture repair, reducing the need for repeat surgeries.
What could go wrong
This is a small, observational study with no comparison group, so results may not apply to all patients. Implants can still fail or cause complications like dislocation or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DISPLACED INTRACAPSULAR HIP FRACTURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Femoral Fractures femoral neck fracture hip fracture osteoarthritis, hip

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FEMORAL FRACTURES HIP ARTHROPATHY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Splošna bolnišnica Celje

    RECRUITING

    Celje, 3000, Slovenia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.